A Trial to Evaluate Safety of Firmagon® (Degarelix) in Indian Patients Diagnosed With Advanced Hormone-dependent Prostate Cancer

NCT02726009 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
230
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Ferring Pharmaceuticals